U. K. Rinne

8.5k total citations
228 papers, 6.2k citations indexed

About

U. K. Rinne is a scholar working on Neurology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, U. K. Rinne has authored 228 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Neurology, 50 papers in Cellular and Molecular Neuroscience and 33 papers in Physiology. Recurrent topics in U. K. Rinne's work include Parkinson's Disease Mechanisms and Treatments (99 papers), Neurological disorders and treatments (64 papers) and Neuroscience and Neuropharmacology Research (20 papers). U. K. Rinne is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (99 papers), Neurological disorders and treatments (64 papers) and Neuroscience and Neuropharmacology Research (20 papers). U. K. Rinne collaborates with scholars based in Finland, Denmark and France. U. K. Rinne's co-authors include R. J. Marttila, V. Sonninen, Juha O. Rinne, Hanna Ruottinen, P.K. Mölsä, P. Riekkinen, A. Laihinen, E Kivalo, Harri Lorentz and T. Siirtola and has published in prestigious journals such as Nature, The Lancet and Neurology.

In The Last Decade

U. K. Rinne

202 papers receiving 5.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
U. K. Rinne Finland 46 3.6k 2.0k 905 771 756 228 6.2k
G M Stern United Kingdom 41 3.8k 1.0× 1.6k 0.8× 641 0.7× 650 0.8× 464 0.6× 111 5.7k
E. Melamed Israel 37 2.3k 0.6× 1.7k 0.8× 1.0k 1.1× 369 0.5× 728 1.0× 117 5.1k
J. William Langston United States 39 4.1k 1.1× 3.1k 1.6× 1.2k 1.3× 332 0.4× 617 0.8× 78 6.3k
Seppo Kaakkola Finland 40 2.6k 0.7× 1.8k 0.9× 2.3k 2.6× 707 0.9× 1.0k 1.3× 87 6.8k
Peter A. LeWitt United States 48 5.0k 1.4× 2.1k 1.1× 1.2k 1.3× 620 0.8× 1.2k 1.6× 200 8.1k
Lucien Côté United States 35 3.1k 0.8× 1.4k 0.7× 752 0.8× 535 0.7× 741 1.0× 59 4.8k
G. Frederick Wooten United States 42 2.1k 0.6× 2.8k 1.4× 1.6k 1.8× 712 0.9× 624 0.8× 108 5.9k
Thomas Müller Germany 42 4.1k 1.1× 1.9k 1.0× 1.3k 1.4× 553 0.7× 733 1.0× 251 6.7k
H. Przuntek Germany 50 4.6k 1.3× 3.3k 1.7× 2.2k 2.5× 637 0.8× 781 1.0× 279 9.0k
Clive Harper Australia 40 1.6k 0.4× 1.2k 0.6× 1.0k 1.1× 322 0.4× 601 0.8× 114 5.0k

Countries citing papers authored by U. K. Rinne

Since Specialization
Citations

This map shows the geographic impact of U. K. Rinne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. K. Rinne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. K. Rinne more than expected).

Fields of papers citing papers by U. K. Rinne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U. K. Rinne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. K. Rinne. The network helps show where U. K. Rinne may publish in the future.

Co-authorship network of co-authors of U. K. Rinne

This figure shows the co-authorship network connecting the top 25 collaborators of U. K. Rinne. A scholar is included among the top collaborators of U. K. Rinne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U. K. Rinne. U. K. Rinne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tedroff, Joakim, Sten‐Magnus Aquilonius, A. Laihinen, et al.. (2009). Striatal kinetics of [11C]-(+)-nomifensine and 6-[18F]fluoro-L-dopa in Parkinson's disease measured with positron emission tomography. Acta Neurologica Scandinavica. 81(1). 24–30. 5 indexed citations
2.
Przuntek, H., Bettina Conrad, J. Dichgans, et al.. (1999). SELEDO: a 5‐y‐ear long‐term trial on the effect of selegiline in early parkinsonian patients treated with levodopa. European Journal of Neurology. 6(2). 141–150. 82 indexed citations
3.
Rinne, U. K., F. Bracco, C Chouza, et al.. (1997). Cabergoline in the treatment of early parkinson's disease. Neurology. 48(2). 363–368. 96 indexed citations
4.
Ruottinen, Hanna, Juha O. Rinne, Ulla Ruotsalainen, et al.. (1995). Striatal [18F]fluorodopa utilization after COMT inhibition with entacapone studied with PET in advanced Parkinson's disease. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 10(2-3). 91–106. 32 indexed citations
5.
Collan, Yrjö, et al.. (1995). Cell counts in the substantia nigra: a comparison of single section counts and disector counts in patients with Parkinson's disease and in controls. Neuropathology and Applied Neurobiology. 21(1). 10–17. 52 indexed citations
6.
Emre, Murat, U. K. Rinne, A Rascol, et al.. (1992). Effects of a selective partil D1 agonist, CY 208‐243, in de novo patients with Parkinson disease. Movement Disorders. 7(3). 239–243. 34 indexed citations
7.
Rinne, Juha O., A. Laihinen, Kjell Någren, et al.. (1990). PET demonstrates different behaviour of striatal dopamine D‐1 and D‐2 receptors in early Parkinson's disease. Journal of Neuroscience Research. 27(4). 494–499. 56 indexed citations
8.
Tenovuo, Olli, et al.. (1990). Brain substance P receptors in Parkinson's disease.. PubMed. 53. 145–8. 12 indexed citations
9.
Marttila, R. J., Jaakko Kaprio, Markku Koskenvuo, & U. K. Rinne. (1988). Parkinson's disease in a nationwide twin cohort. Neurology. 38(8). 1217–1217. 97 indexed citations
10.
Marttila, R. J., M. R�ytt�, Harri Lorentz, & U. K. Rinne. (1988). Oxygen toxicity protecting enzymes in the human brain. Journal of Neural Transmission. 74(2). 87–95. 56 indexed citations
11.
Marttila, R. J., Harri Lorentz, & U. K. Rinne. (1988). Oxygen toxicity protecting enzymes in Parkinson's disease. Journal of the Neurological Sciences. 86(2-3). 321–331. 201 indexed citations
12.
Rinne, U. K.. (1987). Madopar HBS in the Long-Term Treatment of Parkinsonian Patients with Fluctuations in Disability. European Neurology. 27(1). 120–125. 9 indexed citations
13.
Marttila, R. J., Jaakko Kaprio, Markku Koskenvuo, & U. K. Rinne. (1986). FINNISH PARKINSONS-DISEASE TWIN STUDY - PRELIMINARY-RESULTS. Upsala Journal of Medical Sciences. 93–93. 1 indexed citations
14.
Rinne, Juha O., K. Laakso, P. Lönnberg, et al.. (1985). Brain muscarinic receptors in senile dementia. Brain Research. 336(1). 19–25. 78 indexed citations
15.
Rinne, U. K., J. K. Rinne, Juha O. Rinne, et al.. (1983). Brain enkephalin receptors in Parkinson's disease.. PubMed. 19. 163–71. 14 indexed citations
16.
Shand, David G., Michael R. Hall, Stephen H. Buck, et al.. (1982). Opening Remarks by Prof. M. Bergener, Köln. Gerontology. 28(1). 1–4. 3 indexed citations
17.
Pekkarinen, A., et al.. (1972). Effects of L-dopa on plasma growth hormones and insulin.. PubMed. 51. 125–6. 1 indexed citations
18.
Salmi, A., M. Panelius, P. Halonen, U. K. Rinne, & K Penttinen. (1972). Measles Virus Antibody in Cerebrospinal Fluids from Patients with Multiple Sclerosis. BMJ. 1(5798). 477–479. 29 indexed citations
19.
Panelius, M., G. Myllylä, K Penttinen, P. Halonen, & U. K. Rinne. (1970). Platelet Aggregation Test with Measles Antigen in Multiple Sclerosis. BMJ. 2(5707). 461–462. 6 indexed citations
20.
Rinne, U. K.. (1963). Neurosecretory material passing into the hypophysial portal system in the human infundibulum, and its foetal development. Journal of Neural Transmission. 25(3). 310–324. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G M Stern Breakdown of academic impact, for papers by E. Melamed Breakdown of academic impact, for papers by J. William Langston Breakdown of academic impact, for papers by Seppo Kaakkola Breakdown of academic impact, for papers by Peter A. LeWitt Breakdown of academic impact, for papers by Lucien Côté Breakdown of academic impact, for papers by G. Frederick Wooten Breakdown of academic impact, for papers by Thomas Müller Breakdown of academic impact, for papers by H. Przuntek Breakdown of academic impact, for papers by Clive Harper
Rankless by CCL
2026